Skip to main content
Premium Trial:

Request an Annual Quote

Millipore Prices Previously Disclosed $550M Offering

NEW YORK, June 7 (GenomeWeb News) - Millipore will offer $550 million of convertible senior notes with 3.75 percent annual interest, the company said today.

As GenomeWeb News reported yesterday, the Billerica, Mass.-based company will use the funds to finance its acquisition of Serologicals.

As previously reported, the notes will be convertible into cash and shares of Millipore's common stock. The initial conversion rate is 11.0485 shares per $1,000 principal amount of notes, representing an initial conversion price of approximately $90.51 per share.

The sale of the notes is expected to close on June 13.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.